14 Publications
2016
MY APPROACH to testosterone replacement in older men.
Walsh, James P
Trends in cardiovascular medicine, vol. 26, (no. 3), pp. 295-296, April 2016. | Journal Article
2015
PCSK9 inhibitors for LDL lowering
Walsh, James P
(pp. 575-577). Oct 2015
 
PCSK9 inhibitors for LDL lowering.
Walsh, James P
(pp. 575-577). October 2015
 
Testosterone therapy and cardiovascular risk.
Walsh, James P and Kitchens, Anne C
Trends in cardiovascular medicine, vol. 25, (no. 3), pp. 250-257, April 2015. | Journal Article
2013
Percutaneous Coronary Intervention Versus Coronary Bypass Surgery in United States Veterans With Diabetes
Kamalesh, Masoor⋅Kamalesh, Masoor⋅Sharp, Thomas G⋅Sharp, Thomas G⋅Tang, X C⋅Tang, X C⋅Shunk, Kendrick⋅Shunk, Kendrick⋅Ward, Herbert B⋅Ward, Herbert B⋅Walsh, James⋅Walsh, James⋅King, Spencer⋅King, Spencer⋅Colling, Cindy⋅Colling, Cindy⋅Moritz, Thomas⋅Moritz, Thomas⋅Stroupe, Kevin⋅Stroupe, Kevin⋅Reda, Domenic and Reda, Domenic
Journal of the American College of Cardiology, vol. 61, (no. 8), pp. 808-16, Feb 26, 2013. | Journal Article
2011
Lanthanum carbonate interference with lumbar spine DXA.
Walsh, James P and Lteif, Amale A
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, vol. 14, (no. 4), pp. 499-501, 2011 Oct-Dec. | Journal Article
2009
Type B insulin resistance developing during interferon-alpha therapy.
Daniel, Amanda L⋅Daniel, Amanda⋅Houlihan, Josetta⋅Houlihan, Josetta L⋅Blum, Janice S⋅Blum, Janice⋅Walsh, James P and Walsh, James
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, vol. 15, (no. 2), pp. 153-7, 2009/Mar. | Journal Article
2004
L-carnitine may attenuate free fatty acid-induced endothelial dysfunction.
Shankar, Sudha S⋅Mirzamohammadi, Bahram⋅Walsh, James P and Steinberg, Helmut O
Annals of the New York Academy of Sciences, vol. 1033, pp. 189-97, 2004/Nov. | Journal Article
2003
Site-directed mutagenesis of the active site of diacylglycerol kinase alpha: calcium and phosphatidylserine stimulate enzyme activity via distinct mechanisms.
Abe, Takahiro⋅Lu, Xiaolan⋅Jiang, Ying⋅Boccone, Clark E⋅Qian, Shaomin⋅Vattem, Krishna M⋅Wek, Ronald C and Walsh, James P
The Biochemical journal, vol. 375, (no. Pt 3), pp. 673-80, 2003/Nov/1. | Journal Article
2001
A method for quantitative extraction of sphingosine 1-phosphate into organic solvent.
Kralik, S F⋅Du, X⋅Patel, C and Walsh, James P
Analytical biochemistry, vol. 294, (no. 2), pp. 190-3, 2001/Jul/15. | Journal Article
 
Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells.
Du, X⋅Jiang, Y⋅Qian, W⋅Lu, X and Walsh, James P
The Biochemical journal, vol. 357, (no. Pt 1), pp. 275-82, 2001/Jul/1. | Journal Article
2000
A Domain with Homology to Neuronal Calcium Sensors Is Required for Calcium-dependent Activation of Diacylglycerol Kinase alpha
Jiang, Y.⋅Qian, W.⋅Hawes, John W and Walsh, James P
Journal of Biological Chemistry, vol. 275, (no. 44), pp. 34092-34099, 2000. | Journal Article
 
Fatty acids modulate protein kinase C activation in porcine vascular smooth muscle cells independently of their effect on de novo diacylglycerol synthesis.
Lu, X⋅Yang, X Y⋅Howard, R L and Walsh, James P
Diabetologia, vol. 43, (no. 9), pp. 1136-44, 2000/Sep. | Journal Article
 
Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1H)quinazolinone (R59949) among diacylglycerol kinase subtypes.
Jiang, Y⋅Sakane, F⋅Kanoh, H and Walsh, James P
Biochemical pharmacology, vol. 59, (no. 7), pp. 763-72, 2000/Apr/1. | Journal Article